Blogs & Articles

This article discusses how digital transformation is enhancing R&D efficiency in the pharmaceutical and chemical industries.

This article explores how Revvity Signals Solutions are transforming drug discovery by addressing inefficiencies in pharma and biotech workflows.

This article discusses the role of end-to-end R&D solutions in enhancing drug development efficiency by streamlining data capture, collaboration, and regulatory compliance.

The article discusses strategies for overcoming productivity challenges in chemical R&D by leveraging digital solutions.

Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.

Modern drug discovery and biosimilar development projects generate very large volumes of data, yet results held in proprietary, legacy and device-dependent unstructured formats can limit access and lead to increased costs and lengthened delays. Help is at hand, with new AI solutions able to find, process, and summarize data from almost any source in near-real-time, transforming productivity.

This article discusses how integrating technologies like AI, machine learning, and data analytics can enhance drug development efficiency in India's pharmaceutical industry.

This article explores the adoption of Electronic Lab Notebooks (ELNs) in India's pharmaceutical sector, emphasizing their role in enhancing research efficiency, collaboration, and compliance.

This article highlights how Electronic Lab Notebooks (ELNs) are transforming research workflows in India's life sciences sector.

This article highlights the growing adoption of Electronic Lab Notebooks (ELNs) in India's pharmaceutical sector to improve research efficiency, compliance, and innovation.

This article discusses how the chemical industry in India is embracing digital technologies like Electronic Lab Notebooks (ELNs) to streamline R&D workflows, improve data management, and enhance regulatory compliance.